Home > Analytics > INDRAPRASTHA MEDICAL CORPORATION

INDRAPRASTHA MEDICAL CORPORATION
Intrinsic Value | Fundamental Analysis

BOM : 532150     NSE : INDRAMEDCO    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Jun 17,2026
Price(EOD): ₹ 380.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Hospital & Healthcare Services
MCap: ₹ 3,491.02 Cr
Value of ₹ 1 Lac invested in INDRAPRASTHA MEDICAL CORPORATION
on Jun 17,2021 (price: ₹ 89.55)

₹ 1 L

₹ 4.25 L

1W : 1.2% 1M : 5.7% 1Y : -8.7%
COMMUNITY POLL
for INDRAPRASTHA MEDICAL CORPORATION
Please provide your vote to see the results
INDRAPRASTHA MEDICAL CORPORATION is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
INDRAPRASTHA MEDICAL CORPORATION 1.2% 5.7% -8.7%
APOLLO HOSPITALS ENTERPRISE -0.8% 5.1% 21.1%
MAX HEALTHCARE INSTITUTE 1.7% -3.1% -13.6%
FORTIS HEALTHCARE -4% -1.3% 26.8%
ASTER DM HEALTHCARE -5.9% 1.5% 36.6%
NARAYANA HRUDAYALAYA -1% -1.3% 1.5%
GLOBAL HEALTH 2.1% 1.2% 3.3%
KRISHNA INSTITUTE OF MEDICAL SCIENCES 4.1% 11% 15.9%
DR LAL PATHLABS 3.6% 0.3% 10.2%

FUNDAMENTAL ANALYSIS OF INDRAPRASTHA MEDICAL CORPORATION

 
Fundamentals Score
[ Q(TTM): Mar2026, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 INDRAMEDCO is one of the top 24% companies with good fundamentals ! Discover More →


VALUATION OF INDRAPRASTHA MEDICAL CORPORATION

 
Valuation Score
[As on : Jun 17,2026 ]

Ratio Standalone
P/E
P/B
P/S
19.01
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 183.62 Cr
[Latest Qtr - Mar2026 - Standalone Results ]

4.71
P/B Calculated based on Book Value of Rs 740.37 Cr
[Latest Year - Mar2026 - Standalone Results ]

2.35
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2026 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 26% undervalued companies ! Discover More →

FAIR VALUE OF INDRAPRASTHA MEDICAL CORPORATION

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
69%
138%
237%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF INDRAPRASTHA MEDICAL CORPORATION



INDRAPRASTHA MEDICAL CORPORATION vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF INDRAPRASTHA MEDICAL CORPORATION

Year Debt/Equity ratio
Standalone Consolidated
2025
2024
2023
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Mar2025]
Financial Ratios →

PLEDGED PROMOTER SHARES OF INDRAPRASTHA MEDICAL CORPORATION

Pledged Promoter Shares
0 %
As on : Mar2026

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF INDRAPRASTHA MEDICAL CORPORATION

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-1.83%
-2.32%
-2.45%
1.71%
9.31%
-1.32%
-0.47%
1.68%
QtrlyTrend
-2
Latest Qtr: Mar2026
Quarterly Result Analysis →


INDRAPRASTHA MEDICAL CORPORATION related INDICES

BSE Indices1W1M1Y
BSE 1000 4% 2.8% -1%
BSE HEALTHCARE 0.2% -0.3% 7.7%
BSE HOSPITALS -0.7% 1.1% NA
No NSE index found

You may also like the below Video Courses


FAQ about INDRAPRASTHA MEDICAL CORPORATION


Is INDRAPRASTHA MEDICAL CORPORATION good for long term investment?

As on Jun 17,2026, the Fundamentals of INDRAPRASTHA MEDICAL CORPORATION look Strong and hence it may be good for long term investment! See Financial Performance of INDRAPRASTHA MEDICAL CORPORATION . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is INDRAPRASTHA MEDICAL CORPORATION UnderValued or OverValued?

As on Jun 17,2026, INDRAPRASTHA MEDICAL CORPORATION is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of INDRAPRASTHA MEDICAL CORPORATION ?

As on Jun 17,2026, the Intrinsic Value of INDRAPRASTHA MEDICAL CORPORATION is Rs. 160.28 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 225.28
Fair Value [Median EV / Sales Model] : Rs. 160.28
Fair Value [Median Price / Sales Model] : Rs. 113.09
Estimated Median Fair Value of INDRAPRASTHA MEDICAL CORPORATION : Rs. 160.28

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is INDRAPRASTHA MEDICAL CORPORATION trading at a Premium or Discount?

As on Jun 17,2026, INDRAPRASTHA MEDICAL CORPORATION is trading at a Premium of 138% based on the estimates of Median Intrinsic Value!